Helius Medical Technologies (NASDAQ:HSDT) Shares Down 0.6%

Helius Medical Technologies, Inc. (NASDAQ:HSDT) shares were down 0.6% on Wednesday . The company traded as low as $1.66 and last traded at $1.79. Approximately 1,335,680 shares changed hands during trading, an increase of 181% from the average daily volume of 476,102 shares. The stock had previously closed at $1.80.

Analysts Set New Price Targets

Separately, Roth Mkm raised their price target on shares of Helius Medical Technologies to $24.00 and gave the company a “buy” rating in a research note on Tuesday, March 5th.

Helius Medical Technologies Trading Down 0.6 %

The stock has a market cap of $1.59 million, a P/E ratio of -0.12 and a beta of 1.60. The business has a 50-day simple moving average of $5.22 and a 200 day simple moving average of $6.37.

Helius Medical Technologies (NASDAQ:HSDT) last posted its quarterly earnings data on Thursday, March 28th. The company reported ($1.47) EPS for the quarter, topping analysts’ consensus estimates of ($4.05) by $2.58. The company had revenue of $0.13 million for the quarter, compared to analyst estimates of $0.18 million. Helius Medical Technologies had a negative return on equity of 221.11% and a negative net margin of 1,374.22%. As a group, equities analysts expect that Helius Medical Technologies, Inc. will post -7.42 earnings per share for the current year.

About Helius Medical Technologies

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.